Structure-function studies of human FcRn

人FcRn的结构-功能研究

基本信息

  • 批准号:
    7436166
  • 负责人:
  • 金额:
    $ 36.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to gain an improved understanding at the molecular and cellular level of the human form of the MHC Class I-related receptor, FcRn. Recent data suggest that in addition to being the receptor that transports maternal immunoglobulin G (IgG) from mother to young, FcRn regulates the serum levels of IgG. IgG homeostasis is most likely maintained by FcRn expression in endothelial cells of the microvasculature. FcRn is also expressed in epithelial cells at diverse body sites (e.g. intestine, kidney and lung). FcRn transports IgG within (recycling) and across (transcytosis) cells, and is a protective receptor which salvages IgG from lysosomal degradation. Although human FcRn (hFcRn) and mouse FcRn (mFcRn) share about 65% amino acid identity, recent studies indicate that there are significant differences in IgG binding specificity. Intracellular trafficking studies of hFcRn and rat FcRn (highly homologous to mFcRn) suggest that there may also be variations at this level. As a result, studies in mice may not always be reliable indicators of hFcRn function. The current study is directed towards better understanding the similarities and differences between human and mouse FcRn. In turn, this should lead to improved knowledge of hFcRn. Our specific aims are: 1)To understand the molecular basis of the distinct binding specificity of hFcRn. 2) To assess the effects of IgG mutations on functional activity in mouse and human systems. 3) To analyze the intracellular trafficking of hFcRn in endothelial cells. Our studies are therefore directed towards addressing the fundamental question as to how hFcRn functions to maintain serum IgG levels, with a particular focus on hFcRn-lgG interactions and hFcRn trafficking in endothelial cells. This impacts the successful application of therapeutic and prophylactic IgGs, and also has broader relevance to the factors that regulate humoral immunity.
描述(由申请人提供):本提案的目的是在分子和细胞水平上更好地了解人型MHC I类相关受体FcRn。最近的数据表明,除了作为将母体免疫球蛋白G(IgG)从母体转运至幼仔的受体之外,FcRn还调节IgG的血清水平。IgG稳态最有可能通过微血管内皮细胞中的FcRn表达来维持。FcRn还在不同身体部位(例如肠、肾和肺)的上皮细胞中表达。FcRn在细胞内(再循环)和跨细胞(转胞吞)转运IgG,并且是从溶酶体降解中挽救IgG的保护性受体。尽管人FcRn(hFcRn)和小鼠FcRn(mFcRn)共享约65%的氨基酸同一性,但最近的研究表明IgG结合特异性存在显著差异。hFcRn和大鼠FcRn(与mFcRn高度同源)的细胞内转运研究表明,在该水平也可能存在变异。因此,小鼠研究可能并不总是hFcRn功能的可靠指标。目前的研究旨在更好地了解人类和小鼠FcRn之间的相似性和差异。反过来,这将导致对hFcRn的了解得到改善。我们的具体目标是:1)理解hFcRn的不同结合特异性的分子基础。2)评估IgG突变对小鼠和人体系统功能活性的影响。3)分析hFcRn在内皮细胞中的胞内运输。因此,我们的研究旨在解决关于hFcRn如何发挥功能以维持血清IgG水平的基本问题,特别关注hFcRn-IgG相互作用和hFcRn在内皮细胞中的运输。这影响了治疗性和预防性IgG的成功应用,并且还与调节体液免疫的因子具有更广泛的相关性。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dual objective fluorescence microscopy for single molecule imaging applications.
用于单分子成像应用的双物镜荧光显微镜。
HOW ACCURATELY CAN A SINGLE MOLECULE BE LOCALIZED WHEN IMAGED THROUGH AN OPTICAL MICROSCOPE?
通过光学显微镜成像时,单个分子的定位精度如何?
Localizing single molecules in three dimensions - a brief review.
在三个维度上定位单个分子 - 简要回顾。
Quantitative study of single molecule location estimation techniques.
  • DOI:
    10.1364/oe.17.023352
  • 发表时间:
    2009-12-21
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Abraham AV;Ram S;Chao J;Ward ES;Ober RJ
  • 通讯作者:
    Ober RJ
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.
  • DOI:
    10.4049/jimmunol.158.5.2211
  • 发表时间:
    1997-03
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    C. Medesan;D. Matesoi;C. Radu;V. Ghetie;E. Ward
  • 通讯作者:
    C. Medesan;D. Matesoi;C. Radu;V. Ghetie;E. Ward
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH SALLY WARD其他文献

ELIZABETH SALLY WARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH SALLY WARD', 18)}}的其他基金

2010 Antibody Biology and Engineering Gordon Research Conference
2010年抗体生物学与工程戈登研究会议
  • 批准号:
    7796947
  • 财政年份:
    2010
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    7847559
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    7522511
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    8955602
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    7656698
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    8274344
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    8076708
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases
FcRn抑制剂治疗IgG介导疾病的机制研究
  • 批准号:
    7990253
  • 财政年份:
    2008
  • 资助金额:
    $ 36.28万
  • 项目类别:
Structure-function studies of human FcRn
人FcRn的结构-功能研究
  • 批准号:
    6898236
  • 财政年份:
    2004
  • 资助金额:
    $ 36.28万
  • 项目类别:
Structure-function studies of human FcRn
人FcRn的结构-功能研究
  • 批准号:
    6817984
  • 财政年份:
    2004
  • 资助金额:
    $ 36.28万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 36.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了